SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 159 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,568,000 | +19.0% | 151,525 | -0.3% | 0.02% | +21.4% |
| Q2 2018 | $2,158,000 | +15.4% | 151,925 | +54.3% | 0.01% | +180.0% |
| Q1 2018 | $1,870,000 | -11.4% | 98,483 | -23.5% | 0.01% | 0.0% |
| Q4 2017 | $2,110,000 | -6.5% | 128,715 | -38.5% | 0.01% | 0.0% |
| Q3 2014 | $2,257,000 | -15.6% | 209,263 | +19.4% | 0.01% | -28.6% |
| Q2 2014 | $2,675,000 | -18.9% | 175,204 | -4.0% | 0.01% | -22.2% |
| Q1 2014 | $3,300,000 | +19.7% | 182,540 | -8.1% | 0.01% | +12.5% |
| Q4 2013 | $2,758,000 | – | 198,534 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
| WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
| Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
| Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
| Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
| Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
| CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
| XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
| Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |